NERSOOV Trademark
Trademark Overview
On Friday, March 1, 2024, a trademark application was filed for NERSOOV with the United States Patent and Trademark Office. The USPTO has given the NERSOOV trademark a serial number of 98429187. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 3, 2024. This trademark is owned by GLAXO GROUP LIMITED. The NERSOOV trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
General Information
| Serial Number | 98429187 |
| Word Mark | NERSOOV |
| Filing Date | Friday, March 1, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 3, 2024 |
Trademark Statements
| Goods and Services | Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 1, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | GLAXO GROUP LIMITED |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
| Party Name | GLAXO GROUP LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Friday, March 1, 2024 | NEW APPLICATION ENTERED |
| Friday, March 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 17, 2024 | ASSIGNED TO EXAMINER |
| Thursday, September 19, 2024 | LETTER OF SUSPENSION E-MAILED |
| Thursday, September 19, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, September 19, 2024 | SUSPENSION LETTER WRITTEN |
| Thursday, October 10, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 10, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, October 15, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 27, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 3, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
